Related Experiment Videos
Eptastigmine-phosphotriesterase combination in DFP intoxication
K Tuovinen1, E Kaliste-Korhonen, F M Raushel
1Department of Physiology, University of Kuopio, Finland.
Toxicology and Applied Pharmacology
|October 1, 1996
Summary
A new therapy combining eptastigmine and phosphotriesterase enhances protection against organophosphate (DFP) poisoning in mice. This combination therapy improved enzyme activity recovery and overall survival compared to phosphotriesterase alone.
Area of Science:
- Toxicology
- Pharmacology
- Biochemistry
Background:
- Organophosphate (OP) compounds are potent neurotoxins that inhibit acetylcholinesterase (AChE).
- Current treatments for OP poisoning have limitations.
- Developing novel therapeutic strategies is crucial for effective OP poisoning management.
Purpose of the Study:
- To evaluate a novel therapeutic combination against organophosphate exposure.
- To investigate the synergistic effects of eptastigmine and phosphotriesterase in mice exposed to diisopropylfluorophosphate (DFP).
Main Methods:
- Mice were pretreated with eptastigmine (a carbamate) followed by DFP exposure.
- Phosphotriesterase (PTE), an organophosphate hydrolase, was administered post-exposure.
- Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) activities were measured in brain, erythrocytes, plasma, and lung tissues.
Main Results:
- Eptastigmine provided longer-lasting AChE inhibition than physostigmine with fewer behavioral side effects.
- The combination of eptastigmine and PTE significantly enhanced the protective effect against DFP compared to PTE alone.
- Plasma BChE activity doubled and recovered faster in the combination therapy group.
- Lung BChE activity recovered to normal levels within 24 hours with combination therapy, whereas PTE alone only restored it to 75% of control.
Conclusions:
- Eptastigmine pretreatment potentiates the protective efficacy of phosphotriesterase against DFP-induced organophosphate toxicity.
- This combination therapy offers a promising approach for managing organophosphate poisoning.
- Eptastigmine may enhance PTE's efficacy by increasing the availability of free DFP for hydrolysis.